Filing Details
- Accession Number:
- 0001062993-22-022923
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-11-29 16:57:01
- Reporting Period:
- 2022-11-29
- Accepted Time:
- 2022-11-29 16:57:01
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1455365 | Cognition Therapeutics Inc | CGTX | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1281526 | B Ellen Richstone | C/O Cognition Therapeutics, Inc. 2500 Westchester Ave. Purchase NY 10577 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-11-29 | 10,000 | $2.66 | 10,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- Represents the weighted average purchase price. The shares were purchased at prices ranging from $2.61 to $2.67 per share. The reporting person undertakes to provide to Cognition Therapeutics, Inc., any security holder of Cognition Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.